Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity

巨噬细胞在有机磷农药引起的气道高反应性中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): We have demonstrated that in a guinea pig model, organophosphorus pesticides (OPs) cause airway hyperreactivity that is dose-related and associated with the functional loss of autoinhibitory muscarinic M2 receptors that normally limit acetylcholine release from parasympathetic nerves that innervate airway smooth muscle. We recently reported that sensitization to antigen alters the mechanisms underlying OP-induced airway hyperreactivity to involve IL-5-dependent mechanisms in the sensitized but not the non-sensitized guinea pig. How OPs cause neuronal M2 dysfunction in the non-sensitized animal is not known but our preliminary data indicate that this effect is not mediated by cholinesterase inhibition or direct antagonistic interactions with neuronal M2 receptors. Rather, OPs appear to influence neuronal M2 receptor function indirectly via effects on macrophages since depletion of macrophages using liposome-encapsulated clodronate protects against OP-induced airway hyperreactivity. It is our hypothesis that OPs activate macrophages to upregulate expression and release of inflammatory cytokines previously shown to cause M2 receptor dysfunction in various models of airway hyperreactivity. We propose four Aims to test this hypothesis. In Aim 1, we will use in vivo physiological measurements to confirm that macrophages mediate airway hyperreactivity caused by OPs and determine whether their role changes over time, as has been observed for eosinophils in ozone-induced airway hyperreactivity. Aim 2 will utilize macrophages isolated from bronchoalveolar lavage collected from OP-treated versus untreated guinea pigs guinea pigs to examine the effect of OPs on macrophage expression and release of inflammatory cytokines implicated in airway hyperreactivity. In Aim 3, we will use primary nerve cell cultures to determine whether OP- induced macrophage mediators interact with nerves directly to alter M2 receptor expression or function or the structural plasticity of nerves. Aim 4 will confirm the in vivo physiological relevance of OP-induced macrophage mediators identified in aims 2 and 3. Mechanistic studies are critical to developing preventive and therapeutic approaches for OP-induced airway hyperreactivity, which are likely to differ between sensitized (allergic) and non-sensitized individuals, and for determining the risks to human health posed by OP exposures. The public health implications of these studies are significant in light of the increasing prevalence of asthma, the wide spread exposure of humans and especially children to OPs and the credible threat of terrorist use of OP pesticides and nerve agents.
描述(由申请人提供):我们已经证明,在豚鼠模型中,有机磷农药(OP)会引起气道高反应性,这种反应性与剂量相关,并与通常限制支配气道平滑肌的副交感神经释放乙酰胆碱的自抑制性毒蕈碱M2受体功能丧失有关。我们最近报道,对抗原的致敏改变了 OP 诱导的气道高反应性的机制,涉及致敏但非致敏豚鼠中的 IL-5 依赖性机制。 OP 如何在非致敏动物中引起神经元 M2 功能障碍尚不清楚,但我们的初步数据表明,这种效应不是通过胆碱酯酶抑制或与神经元 M2 受体的直接拮抗相互作用介导的。相反,OP 似乎通过对巨噬细胞的影响间接影响神经元 M2 受体功能,因为使用脂质体封装的氯膦酸盐消耗巨噬细胞可以防止 OP 诱导的气道高反应性。我们的假设是,OP 激活巨噬细胞上调炎症细胞因子的表达和释放,此前已证明这些细胞因子会在各种气道高反应性模型中导致 M2 受体功能障碍。我们提出四个目标来检验这一假设。在目标 1 中,我们将使用体内生理测量来确认巨噬细胞介导 OP 引起的气道高反应性,并确定其作用是否随时间而变化,正如在臭氧诱导的气道高反应性中观察到的嗜酸性粒细胞一样。目标 2 将利用从经 OP 处理的豚鼠和未处理的豚鼠收集的支气管肺泡灌洗液中分离出的巨噬细胞,来检查 OP 对巨噬细胞表达和与气道高反应性有关的炎症细胞因子释放的影响。在目标 3 中,我们将使用原代神经细胞培养物来确定 OP 诱导的巨噬细胞介质是否直接与神经相互作用,从而改变 M2 受体的表达或功能或神经的结构可塑性。目标 4 将确认目标 2 和 3 中确定的 OP 诱导的巨噬细胞介质的体内生理相关性。机制研究对于开发 OP 诱导的气道高反应性的预防和治疗方法至关重要,这在致敏(过敏)和非致敏个体之间可能有所不同,并且对于确定 OP 暴露对人类健康造成的风险至关重要。鉴于哮喘患病率不断上升、人类(尤其是儿童)广泛接触有机磷农药,以及恐怖分子使用有机磷农药和神经毒剂的可信威胁,这些研究对公共卫生的影响意义重大。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pioglitazone prevents obesity-related airway hyperreactivity and neuronal M2 receptor dysfunction.
吡格列酮可预防肥胖相关的气道高反应性和神经元 M2 受体功能障碍。
Oxygen tension modulates differentiation and primary macrophage functions in the human monocytic THP-1 cell line.
  • DOI:
    10.1371/journal.pone.0054926
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Grodzki AC;Giulivi C;Lein PJ
  • 通讯作者:
    Lein PJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALLISON Deborah FRYER其他文献

ALLISON Deborah FRYER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALLISON Deborah FRYER', 18)}}的其他基金

Insulin increases nerve-mediated bronchoconstriction in obesity-related asthma
胰岛素增加肥胖相关哮喘中神经介导的支气管收缩
  • 批准号:
    10587344
  • 财政年份:
    2022
  • 资助金额:
    $ 33.96万
  • 项目类别:
Oregon Clinical and Translational Research Institute TL1 Program
俄勒冈临床和转化研究所 TL1 项目
  • 批准号:
    9514380
  • 财政年份:
    2017
  • 资助金额:
    $ 33.96万
  • 项目类别:
NRSA Training Core
NRSA 培训核心
  • 批准号:
    10693309
  • 财政年份:
    2017
  • 资助金额:
    $ 33.96万
  • 项目类别:
Oregon Clinical and Translational Research Institute TL1 Program
俄勒冈临床和转化研究所 TL1 项目
  • 批准号:
    10197247
  • 财政年份:
    2017
  • 资助金额:
    $ 33.96万
  • 项目类别:
NRSA Training Core
NRSA 培训核心
  • 批准号:
    10675197
  • 财政年份:
    2017
  • 资助金额:
    $ 33.96万
  • 项目类别:
Insulin Modulates Parasympathetic Nerve Control of Lungs
胰岛素调节肺的副交感神经控制
  • 批准号:
    9233398
  • 财政年份:
    2016
  • 资助金额:
    $ 33.96万
  • 项目类别:
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity
巨噬细胞在有机磷农药引起的气道高反应性中的作用
  • 批准号:
    8106431
  • 财政年份:
    2010
  • 资助金额:
    $ 33.96万
  • 项目类别:
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity
巨噬细胞在有机磷农药引起的气道高反应性中的作用
  • 批准号:
    8462262
  • 财政年份:
    2010
  • 资助金额:
    $ 33.96万
  • 项目类别:
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity
巨噬细胞在有机磷农药引起的气道高反应性中的作用
  • 批准号:
    8008728
  • 财政年份:
    2010
  • 资助金额:
    $ 33.96万
  • 项目类别:
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity
巨噬细胞在有机磷农药引起的气道高反应性中的作用
  • 批准号:
    8272650
  • 财政年份:
    2010
  • 资助金额:
    $ 33.96万
  • 项目类别:

相似海外基金

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
  • 批准号:
    10739853
  • 财政年份:
    2023
  • 资助金额:
    $ 33.96万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10772738
  • 财政年份:
    2023
  • 资助金额:
    $ 33.96万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10303546
  • 财政年份:
    2021
  • 资助金额:
    $ 33.96万
  • 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
  • 批准号:
    10378934
  • 财政年份:
    2021
  • 资助金额:
    $ 33.96万
  • 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
  • 批准号:
    2480200
  • 财政年份:
    2020
  • 资助金额:
    $ 33.96万
  • 项目类别:
    Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    9977281
  • 财政年份:
    2019
  • 资助金额:
    $ 33.96万
  • 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    10238898
  • 财政年份:
    2019
  • 资助金额:
    $ 33.96万
  • 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
  • 批准号:
    18K15850
  • 财政年份:
    2018
  • 资助金额:
    $ 33.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
  • 批准号:
    481759-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 33.96万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
  • 批准号:
    8735550
  • 财政年份:
    2014
  • 资助金额:
    $ 33.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了